Analysts forecast that DENTSPLY SIRONA Inc. (NASDAQ:XRAY) will announce earnings per share (EPS) of $0.79 for the current quarter, according to Zacks Investment Research. Seven analysts have made estimates for DENTSPLY SIRONA’s earnings, with estimates ranging from $0.73 to $0.81. DENTSPLY SIRONA posted earnings of $0.87 per share during the same quarter last year, which suggests a negative year over year growth rate of 9.2%. The firm is scheduled to issue its next quarterly earnings results on Monday, March 7th.
According to Zacks, analysts expect that DENTSPLY SIRONA will report full year earnings of $2.89 per share for the current financial year, with EPS estimates ranging from $2.84 to $2.92. For the next financial year, analysts forecast that the firm will post earnings of $3.18 per share, with EPS estimates ranging from $2.96 to $3.36. Zacks’ earnings per share averages are an average based on a survey of sell-side research analysts that cover DENTSPLY SIRONA.
DENTSPLY SIRONA (NASDAQ:XRAY) last issued its earnings results on Thursday, November 4th. The medical instruments supplier reported $0.68 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.65 by $0.03. DENTSPLY SIRONA had a net margin of 9.85% and a return on equity of 13.05%. The company had revenue of $1.07 billion for the quarter, compared to analysts’ expectations of $1.02 billion. During the same period in the prior year, the company earned $0.67 earnings per share. The firm’s revenue was up 19.4% compared to the same quarter last year.
In other news, SVP Lisa Yankie sold 1,903 shares of DENTSPLY SIRONA stock in a transaction that occurred on Friday, November 19th. The shares were sold at an average price of $52.63, for a total value of $100,154.89. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, insider Walter Petersohn sold 86,431 shares of DENTSPLY SIRONA stock in a transaction on Wednesday, November 17th. The stock was sold at an average price of $54.18, for a total transaction of $4,682,831.58. The disclosure for this sale can be found here. 0.69% of the stock is currently owned by company insiders.
A number of large investors have recently added to or reduced their stakes in the business. Price T Rowe Associates Inc. MD raised its stake in shares of DENTSPLY SIRONA by 16.1% during the 2nd quarter. Price T Rowe Associates Inc. MD now owns 18,345,432 shares of the medical instruments supplier’s stock worth $1,160,532,000 after purchasing an additional 2,546,458 shares in the last quarter. BlackRock Inc. raised its stake in shares of DENTSPLY SIRONA by 7.0% during the 3rd quarter. BlackRock Inc. now owns 16,991,458 shares of the medical instruments supplier’s stock worth $986,354,000 after purchasing an additional 1,109,283 shares in the last quarter. Artisan Partners Limited Partnership raised its stake in DENTSPLY SIRONA by 0.4% in the 3rd quarter. Artisan Partners Limited Partnership now owns 11,383,822 shares of the medical instruments supplier’s stock valued at $660,831,000 after acquiring an additional 46,064 shares during the period. State Street Corp raised its stake in DENTSPLY SIRONA by 1.3% in the 2nd quarter. State Street Corp now owns 9,667,282 shares of the medical instruments supplier’s stock valued at $612,593,000 after acquiring an additional 126,604 shares during the period. Finally, Geode Capital Management LLC raised its stake in DENTSPLY SIRONA by 2.8% in the 3rd quarter. Geode Capital Management LLC now owns 4,061,180 shares of the medical instruments supplier’s stock valued at $235,146,000 after acquiring an additional 109,108 shares during the period. 93.46% of the stock is owned by hedge funds and other institutional investors.
Shares of NASDAQ XRAY traded down $0.75 during mid-day trading on Thursday, reaching $51.26. The company had a trading volume of 1,163,448 shares, compared to its average volume of 1,437,835. The stock has a fifty day moving average of $57.08 and a two-hundred day moving average of $61.36. The company has a debt-to-equity ratio of 0.38, a quick ratio of 1.13 and a current ratio of 1.60. The company has a market capitalization of $11.21 billion, a price-to-earnings ratio of 26.98, a PEG ratio of 0.85 and a beta of 0.88. DENTSPLY SIRONA has a 12-month low of $50.54 and a 12-month high of $69.54.
About DENTSPLY SIRONA
Dentsply Sirona, Inc engages in the design, manufacture, sales and distribution of professional dental products and technologies. It operates through the following segments: Technologies and Equipment and Consumables. The Technologies and Equipment segments comprises dental technology, equipment and healthcare consumable products such as dental implants, laboratory dental products, computer-aided design and computer-aided manufacturing systems, imaging systems, treatment centers and consumable medical device products.
Recommended Story: What is a CD ladder?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.